Vumerity DR 231 MG capsule 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FV898
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,349
Award facts
- Contract value 100% obligated
- $13,348.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $13,348.76 for 120 capsules of Vumerity (dimethyl fumarate) 231 mg. This non-set-aside, firm fixed-price delivery order was awarded on January 29, 2026, with an ultimate completion date of January 30, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999,999,999.00 through December 31, 2031. This IDC serves as a comprehensive pharmaceutical supply vehicle enabling delivery of a broad range of medications, medical supplies, and healthcare commodities to support military healthcare programs globally.
The Vumerity delivery fulfills pharmaceutical supply needs for the federal government's military healthcare system. Vumerity is an approved treatment for multiple sclerosis, indicating this order supports clinical medical requirements within the Defense Health Agency or affiliated military treatment facilities. The Defense Logistics Agency's Medical Supply Chain utilizes AmerisourceBergen's distribution capabilities and extensive pharmaceutical inventory to ensure timely availability of critical medications across military healthcare operations. This delivery order demonstrates the operational utilization of the larger IDC framework to procure specific pharmaceutical products on a competitive, open basis.
Quick answers
Who was awarded contract SPE2DR26FV898?
SPE2DR26FV898 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FV898 worth?
The government has obligated $13,349 on SPE2DR26FV898.
Is contract SPE2DR26FV898 an order under another contract?
Yes. SPE2DR26FV898 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV898 competed?
The extent of competition for SPE2DR26FV898 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award